259 related articles for article (PubMed ID: 28024082)
1. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
2. Insulated Foamy Viral Vectors.
Browning DL; Collins CP; Hocum JD; Leap DJ; Rae DT; Trobridge GD
Hum Gene Ther; 2016 Mar; 27(3):255-66. PubMed ID: 26715244
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
Everson EM; Hocum JD; Trobridge GD
J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
[TBL] [Abstract][Full Text] [Related]
4. Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection.
Olszko ME; Adair JE; Linde I; Rae DT; Trobridge P; Hocum JD; Rawlings DJ; Kiem HP; Trobridge GD
Gene Ther; 2015 Jul; 22(7):591-5. PubMed ID: 25786870
[TBL] [Abstract][Full Text] [Related]
5. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
6. Large animal models for foamy virus vector gene therapy.
Trobridge GD; Horn PA; Beard BC; Kiem HP
Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
[TBL] [Abstract][Full Text] [Related]
8. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
Rethwilm A
Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
[TBL] [Abstract][Full Text] [Related]
9. Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors.
Josephson NC; Vassilopoulos G; Trobridge GD; Priestley GV; Wood BL; Papayannopoulou T; Russell DW
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8295-300. PubMed ID: 12060773
[TBL] [Abstract][Full Text] [Related]
10. Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.
Trobridge GD; Beard BC; Wu RA; Ironside C; Malik P; Kiem HP
PLoS One; 2012; 7(9):e45173. PubMed ID: 23028826
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
Morianos I; Siapati EK; Pongas G; Vassilopoulos G
Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
[TBL] [Abstract][Full Text] [Related]
12. A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance.
Everson EM; Olzsko ME; Leap DJ; Hocum JD; Trobridge GD
Mol Ther Methods Clin Dev; 2016; 3():16048. PubMed ID: 27579335
[TBL] [Abstract][Full Text] [Related]
13. Foamy-virus-mediated gene transfer to canine repopulating cells.
Kiem HP; Allen J; Trobridge G; Olson E; Keyser K; Peterson L; Russell DW
Blood; 2007 Jan; 109(1):65-70. PubMed ID: 16968897
[TBL] [Abstract][Full Text] [Related]
14. A foamy virus vector system for stable and efficient RNAi expression in mammalian cells.
Papadaki M; Siapati EK; Vassilopoulos G
Hum Gene Ther; 2011 Oct; 22(10):1293-303. PubMed ID: 21456885
[TBL] [Abstract][Full Text] [Related]
15. Foamy virus vectors for gene transfer.
Trobridge GD
Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
[TBL] [Abstract][Full Text] [Related]
16. Foamy virus vector integration sites in normal human cells.
Trobridge GD; Miller DG; Jacobs MA; Allen JM; Kiem HP; Kaul R; Russell DW
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1498-503. PubMed ID: 16428288
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
18. FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs.
Simantirakis E; Tsironis I; Vassilopoulos G
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204324
[TBL] [Abstract][Full Text] [Related]
19. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
[TBL] [Abstract][Full Text] [Related]
20. Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors.
Josephson NC; Trobridge G; Russell DW
Hum Gene Ther; 2004 Jan; 15(1):87-92. PubMed ID: 14965380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]